Revolution Medicines Cash Flow from Investing Activities 2018-2025 | RVMD
Revolution Medicines cash flow from investing activities for the twelve months ending March 31, 2025 was $-0.872B, a 47.2% increase year-over-year.
- Revolution Medicines annual cash flow from investing activities for 2024 was $-0.554B, a 61.82% increase from 2023.
- Revolution Medicines annual cash flow from investing activities for 2023 was $-0.343B, a 1320.63% increase from 2022.
- Revolution Medicines annual cash flow from investing activities for 2022 was $-0.024B, a 83.03% decline from 2021.